Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Gillian Margaret McGuire has worked on the following 6 EPO patent applications which have been published in the last five years:

EP16203884

INHIBITORS OF C-FMS KINASE

IPC classification:
A61K 31/33, A61P 19/02, A61P 35/00, C07D 401/14, C07D 405/12, C07D 405/14, C07D 409/14, C07D 471/08, C07D 493/08
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
The application has been published
EP17155466

LACTAM KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, C07D 487/04, C07D 487/14
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
The application has been published
EP15804209

N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS

IPC classification:
A61K 31/415, A61K 31/416, A61K 31/4439, A61K 31/454, A61K 31/4709, A61K 31/497, A61K 31/506, C07D 231/14, C07D 401/06, C07D 401/10, C07D 401/14, C07D 403/10, C07D 405/14, C07D 409/14, C07D 413/14
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15804210

N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS,

IPC classification:
A61K 31/415, A61K 31/454, A61K 31/4709, A61K 31/497, A61K 31/506, C07D 231/14, C07D 401/06, C07D 401/10, C07D 401/14, C07D 403/10, C07D 409/14, C07D 413/14
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15828426

PROCESSES FOR THE PREPARATION OF A DIARYLTHIOHYDANTOIN COMPOUND

IPC classification:
C07D 401/04
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15875711

GLUCAGON DERIVATIVES

IPC classification:
A61K 38/26, A61P 3/04, C07K 14/605
Agent:
Gillian Margaret McGuire, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature